{"transactions":[{"id":1076062,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-08-04T20:47:56.000Z","date":"2025-07-31","kind":"grant","planned":false,"acquired":true,"shares":41035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2025, pursuant to the Transaction Agreement, dated as of March 13, 2025 (as amended, the \"Transaction Agreement\"), by and among Mallinckrodt plc (the \"Issuer\"), Endo, Inc. (\"Endo\") and Salvare Merger Sub LLC, the Issuer's wholly owned subsidiary (\"Merger Sub\"), the Merger Sub merged with and into Endo (the \"Business Combination\"), with Endo surviving the Business Combination as a wholly owned subsidiary of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Upon consummation of the Business Combination, each performance unit (\"PSU\") held by the reporting person automatically converted into a restricted unit (\"RSU\"). Each RSU will fully vest on December 25, 2026."}],"balance_after":54714,"derivative":{"underlying":"Ordinary Shares","underlying_shares":41035},"source":{"system":"sec-edgar","filing":"0001104659-25-073784","document":"tm2522414-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465925073784/tm2522414-19_4seq1.xml","form_type":"4"}},{"id":1318325,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2025-01-02T17:01:25.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":false,"shares":6838,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 2, 2024, the reporting person was granted 20,517 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 2, 2024, the reporting person was granted 20,517 RSUs vesting ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":13679,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6838},"source":{"system":"sec-edgar","filing":"0001104659-25-000368","document":"tm2432211-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465925000368/tm2432211-10_4seq1.xml","form_type":"4"}},{"id":1318324,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2025-01-02T17:01:25.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":1724,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the issuer's ordinary shares are not listed or quoted on a recognized trading market."}],"balance_after":5114,"source":{"system":"sec-edgar","filing":"0001104659-25-000368","document":"tm2432211-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465925000368/tm2432211-10_4seq1.xml","form_type":"4"}},{"id":1318323,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2025-01-02T17:01:25.000Z","date":"2025-01-01","kind":"exercise","planned":false,"acquired":true,"shares":6838,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (the \"RSU\") that was settled, was settled in ordinary shares of the issuer at one share per RSU."}],"balance_after":6838,"source":{"system":"sec-edgar","filing":"0001104659-25-000368","document":"tm2432211-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465925000368/tm2432211-10_4seq1.xml","form_type":"4"}},{"id":1491470,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-06-04T16:30:22.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vested on June 1, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001415889-24-015369","document":"form4-06042024_040618.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000141588924015369/form4-06042024_040618.xml","form_type":"4"}},{"id":1491469,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-04T16:30:22.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":4660,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":28732,"source":{"system":"sec-edgar","filing":"0001415889-24-015369","document":"form4-06042024_040618.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000141588924015369/form4-06042024_040618.xml","form_type":"4"}},{"id":1545251,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-08T21:34:32.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":27229,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.74,"underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001104659-24-044896","document":"tm2411350-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465924044896/tm2411350-8_4seq1.xml","form_type":"4"}},{"id":1545250,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-08T21:34:32.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":118182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each outstanding and unvested option to purchase Shares granted under an Issuer equity plan (each, an \"Issuer Stock Option\") vested in full. At the Effective Time, each Issuer Stock Option with an exercise price that is less than the Offer Amount was cancelled and converted into the right to receive a cash payment equal to the product of (A) the excess, if any, of the Offer Amount over the exercise price payable per Share with respect to such Issuer Stock Option, multiplied by (B) the total number of Shares subject to such Issuer Stock Option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.8,"underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001104659-24-044896","document":"tm2411350-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465924044896/tm2411350-8_4seq1.xml","form_type":"4"}},{"id":1545249,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T21:34:32.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":73620,"price":1.1,"value":80982.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units granted under an Issuer equity plan (\"RSUs\") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-24-044896","document":"tm2411350-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465924044896/tm2411350-8_4seq1.xml","form_type":"4"}},{"id":1545248,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-08T21:34:32.000Z","date":"2024-04-08","kind":"other","planned":false,"acquired":false,"shares":217429,"price":1.1,"value":239171.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Pursuant to the terms of that certain Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation (\"Parent\") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent (\"Merger Sub\"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a \"Share\") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the \"Effective Time\") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the \"Offer Amount\"), subject to any applicable withholding taxes and without interest."}],"balance_after":73620,"source":{"system":"sec-edgar","filing":"0001104659-24-044896","document":"tm2411350-8_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465924044896/tm2411350-8_4seq1.xml","form_type":"4"}},{"id":1656515,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2024-02-06T16:31:55.000Z","date":"2024-02-02","kind":"grant","planned":false,"acquired":false,"shares":20517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") will be settled in ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of January 1, 2024."}],"balance_after":20517,"derivative":{"underlying":"Ordinary Shares","underlying_shares":20517},"source":{"system":"sec-edgar","filing":"0001104659-24-011128","document":"tm245307-13_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465924011128/tm245307-13_4seq1.xml","form_type":"4"}},{"id":1738693,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2023-11-16T16:15:40.000Z","date":"2023-11-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":96660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 28, 2023, Mallinckrodt plc (the \"Company\") and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On September 20, 2023, the Company's directors presented a petition before the High Court of Ireland (the \"Irish High Court\") seeking the appointment of an examiner (the \"Examiner\") to the Company, thereby commencing examinership proceedings with respect to the Company in Ireland."},{"field":"kind","element":"transactionCoding","label":"F2","text":"On October 10, 2023, the Bankruptcy Court entered an order confirming the First Amended Prepackaged Joint Chapter 11 Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates (as may be amended or supplemented from time to time in accordance with its terms, the \"Plan\"). On November 10, 2023, the Irish High Court made an order confirming a scheme of arrangement proposed by the Examiner that is based on and consistent in all respects with the Plan (the \"Scheme\"). On November 14, 2023 (the \"Effective Date\"), the Plan and the Scheme became effective and the Company emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of the Company's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such Ordinary Shares, were cancelled and extinguished pursuant to the Plan and the Scheme. This Form 4 constitutes a notice to the Issuer for purposes of Part V of the Companies Act 2014."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-23-119124","document":"tm2330745-13_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465923119124/tm2330745-13_4seq1.xml","form_type":"4"}},{"id":1795039,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-28T16:32:18.000Z","date":"2023-08-28","kind":"purchase","planned":false,"acquired":true,"shares":62500,"price":0.4,"value":25000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired pursuant to an underwritten public offering of common stock by the Issuer."}],"balance_after":291049,"source":{"system":"sec-edgar","filing":"0001062993-23-017166","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000106299323017166/form4.xml","form_type":"4"}},{"id":1801617,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2023-08-18T21:21:59.000Z","date":"2023-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":15976,"price":0.693,"value":11071.368,"ownership":{"direct":true},"balance_after":96660,"source":{"system":"sec-edgar","filing":"0001104659-23-093621","document":"tm2324159-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465923093621/tm2324159-4_4seq1.xml","form_type":"4"}},{"id":1835258,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T18:16:56.000Z","date":"2023-06-30","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":168237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The restricted stock units (the \"RSUs\") granted on April 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors of Mallinckrodt's approval of a cash-based Key Employee Incentive Plan (\"KEIP\") that replaces the Company's existing 2023 short-term incentive and 2023 long-term incentive (\"2023 LTI\") programs for certain of its key officers, including the reporting person. Participation in the KEIP by the reporting person was subject to the cancelation of the reporting person's prior 2023 LTI program grants, including the reporting person's April 3, 2023 RSU grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The restricted stock units (the \"RSUs\") granted on April 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors of Mallinckrodt's approval of a cash-based Key Employee Incentive Plan (\"KEIP\") that replaces the Company's existing 2023 short-term incentive and 2023 long-term incentive (\"2023 LTI\") programs for certain of its key officers, including the reporting person. Participation in the KEIP by the reporting person was subject to the cancelation of the reporting person's prior 2023 LTI program grants, including the reporting person's April 3, 2023 RSU grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The restricted stock units (the \"RSUs\") granted on April 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors of Mallinckrodt's approval of a cash-based Key Employee Incentive Plan (\"KEIP\") that replaces the Company's existing 2023 short-term incentive and 2023 long-term incentive (\"2023 LTI\") programs for certain of its key officers, including the reporting person. Participation in the KEIP by the reporting person was subject to the cancelation of the reporting person's prior 2023 LTI program grants, including the reporting person's April 3, 2023 RSU grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The restricted stock units (the \"RSUs\") granted on April 3, 2023 were canceled by mutual agreement of the reporting person and Mallinckrodt plc (\"Mallinckrodt\") in connection with the Board of Directors of Mallinckrodt's approval of a cash-based Key Employee Incentive Plan (\"KEIP\") that replaces the Company's existing 2023 short-term incentive and 2023 long-term incentive (\"2023 LTI\") programs for certain of its key officers, including the reporting person. Participation in the KEIP by the reporting person was subject to the cancelation of the reporting person's prior 2023 LTI program grants, including the reporting person's April 3, 2023 RSU grant."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":168237},"source":{"system":"sec-edgar","filing":"0001104659-23-078291","document":"tm2320608-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465923078291/tm2320608-6_4seq1.xml","form_type":"4"}},{"id":1866247,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T16:57:56.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":false,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 2, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-23-034421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919123034421/doc4.xml","form_type":"4"}},{"id":1866246,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-05T16:57:56.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":4660,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 1, 2024, subject to the Reporting Person's continuous service through such date."}],"balance_after":4660,"derivative":{"underlying":"Common Stock","underlying_shares":4660},"source":{"system":"sec-edgar","filing":"0001209191-23-034421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919123034421/doc4.xml","form_type":"4"}},{"id":1866245,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-05T16:57:56.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's ninth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 1, 2023, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":8.7,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-23-034421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919123034421/doc4.xml","form_type":"4"}},{"id":1866244,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-05T16:57:56.000Z","date":"2023-06-02","kind":"exercise","planned":false,"acquired":true,"shares":4507,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":24072,"source":{"system":"sec-edgar","filing":"0001209191-23-034421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919123034421/doc4.xml","form_type":"4"}},{"id":1884155,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T16:55:10.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":27229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 17, 2024, subject to continued service with the Company."}],"balance_after":27229,"derivative":{"exercise_price":0.74,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":27229},"source":{"system":"sec-edgar","filing":"0001062993-23-011843","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000106299323011843/form4.xml","form_type":"4"}},{"id":1884154,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:55:10.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":73620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 17, 2024, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":228549,"source":{"system":"sec-edgar","filing":"0001062993-23-011843","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000106299323011843/form4.xml","form_type":"4"}},{"id":1924602,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Restricted Stock Units","published_at":"2023-04-05T19:06:24.000Z","date":"2023-04-03","kind":"grant","planned":false,"acquired":true,"shares":168237,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Upon vesting, each restricted stock unit (the \"RSU\") may be settled in the discretion of the issuer in cash or ordinary shares of the issuer at one share per RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs will vest ratably on each of the first three anniversaries of the grant date."}],"balance_after":168237,"derivative":{"underlying":"Ordinary Shares","underlying_shares":168237},"source":{"system":"sec-edgar","filing":"0001104659-23-042299","document":"tm2311874-8_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465923042299/tm2311874-8_4seq1.xml","form_type":"4"}},{"id":2077402,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2022-12-22T17:47:19.000Z","date":"2022-12-14","kind":"grant","acquired":true,"shares":112636,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reported ordinary shares represent restricted stock units, which will be settled in an equal number of MNK ordinary shares and will vest ratably on each of the first three anniversaries of August 17, 2022."}],"balance_after":112636,"source":{"system":"sec-edgar","filing":"0001104659-22-129618","document":"tm2233304-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000110465922129618/tm2233304-3_4seq1.xml","form_type":"4"}},{"id":2224947,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2022-06-21T18:23:06.000Z","date":"2022-06-16","kind":"disposition_to_issuer","acquired":false,"shares":57569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 12, 2020, Mallinckrodt plc, an Irish public limited company in examination under Part 10 of the Companies Act 2014 of Ireland (\"Mallinckrodt\"), and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code (the \"Bankruptcy Code\") in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On February 3, 2022, the Bankruptcy Court issued an opinion (which was subsequently revised on February 8, 2022 to make minor corrections) stating its intention to confirm Mallinckrodt's Fourth Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) On March 2, 2022, the Bankruptcy Court entered an order confirming the Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (as amended, supplemented or otherwise modified, the \"Plan\"), and on June 16, 2022 (the \"Effective Date\"), the Plan became effective and Mallinckrodt emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of Mallinckrodt's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such ordinary shares, were cancelled and extinguished pursuant to the Plan."}],"balance_after":0,"derivative":{"exercise_price":22.26,"exercise_date":"2020-04-01","expiration_date":"2029-04-01","underlying":"Ordinary Shares","underlying_shares":57569},"source":{"system":"sec-edgar","filing":"0000899243-22-023452","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000089924322023452/doc4.xml","form_type":"4"}},{"id":2224946,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2022-06-21T18:23:06.000Z","date":"2022-06-16","kind":"disposition_to_issuer","acquired":false,"shares":11593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 12, 2020, Mallinckrodt plc, an Irish public limited company in examination under Part 10 of the Companies Act 2014 of Ireland (\"Mallinckrodt\"), and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code (the \"Bankruptcy Code\") in the U.S. Bankruptcy Court for the District of Delaware (the \"Bankruptcy Court\"). On February 3, 2022, the Bankruptcy Court issued an opinion (which was subsequently revised on February 8, 2022 to make minor corrections) stating its intention to confirm Mallinckrodt's Fourth Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code."},{"field":"kind","element":"transactionCoding","label":"F2","text":"(Continued from Footnote 1) On March 2, 2022, the Bankruptcy Court entered an order confirming the Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (as amended, supplemented or otherwise modified, the \"Plan\"), and on June 16, 2022 (the \"Effective Date\"), the Plan became effective and Mallinckrodt emerged from bankruptcy."},{"field":"kind","element":"transactionCoding","label":"F3","text":"On the Effective Date, all of Mallinckrodt's previously outstanding ordinary shares (the \"Ordinary Shares\"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such ordinary shares, were cancelled and extinguished pursuant to the Plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-22-023452","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000089924322023452/doc4.xml","form_type":"4"}},{"id":2241430,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T17:33:37.000Z","date":"2022-06-03","kind":"exercise","acquired":false,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The shares underlying these restricted stock units vested on June 3, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-22-034606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919122034606/doc4.xml","form_type":"4"}},{"id":2241429,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-06T17:33:37.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":4507,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 2, 2023, subject to the Reporting Person's continuous service through such date."}],"balance_after":4507,"derivative":{"underlying":"Common Stock","underlying_shares":4507},"source":{"system":"sec-edgar","filing":"0001209191-22-034606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919122034606/doc4.xml","form_type":"4"}},{"id":2241428,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-06T17:33:37.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":15750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This grant was made pursuant to the issuer's seventh amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to this option will vest in twelve equal monthly installments commencing July 2, 2022, subject to Reporting Person's continuous service through each such date."}],"balance_after":15750,"derivative":{"exercise_price":14.48,"expiration_date":"2032-06-01","underlying":"Common Stock","underlying_shares":15750},"source":{"system":"sec-edgar","filing":"0001209191-22-034606","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919122034606/doc4.xml","form_type":"4"}},{"id":2241427,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T17:33:37.000Z","date":"2022-06-03","kind":"exercise","acquired":true,"shares":3356,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":19565,"source":{"system":"sec-edgar","filing":"0001209191-22-034606","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919122034606/doc4.xml","form_type":"4"}},{"id":2261451,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-05-20T17:36:24.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":118182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full on May 18, 2023, subject to continued service with the Company."}],"balance_after":118182,"derivative":{"exercise_price":0.8,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":118182},"source":{"system":"sec-edgar","filing":"0001062993-22-013172","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000106299322013172/form4.xml","form_type":"4"}},{"id":2261450,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-20T17:36:24.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":87500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These restricted stock units will vest in full on May 18, 2023, subject to continued service with the Company. Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":154929,"source":{"system":"sec-edgar","filing":"0001062993-22-013172","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000106299322013172/form4.xml","form_type":"4"}},{"id":2680486,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-04T20:09:48.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":3356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units will vest on June 3, 2022, subject to the Reporting Person's continuous service through such date."}],"balance_after":3356,"derivative":{"underlying":"Common Stock","underlying_shares":3356},"source":{"system":"sec-edgar","filing":"0001209191-21-038457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919121038457/doc4.xml","form_type":"4"}},{"id":2680485,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T20:09:48.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This grant was made pursuant to the issuer's fifth amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 3, 2021, subject to Reporting Person's continuous service through each such date."}],"balance_after":12250,"derivative":{"exercise_price":21.9,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":12250},"source":{"system":"sec-edgar","filing":"0001209191-21-038457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919121038457/doc4.xml","form_type":"4"}},{"id":2709944,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-17T16:03:32.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the exercise price of the stock options acquired on April 20, 2021 as reported on the Form 4 filed on April 22, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":2.6,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000430","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248221000430/edgar.xml","form_type":"4/A","original_submission_date":"2021-04-22"}},{"id":2741747,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-22T17:58:12.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":38012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on April 20, 2022."}],"balance_after":38012,"derivative":{"exercise_price":1.71,"expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":38012},"source":{"system":"sec-edgar","filing":"0001192482-21-000351","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248221000351/edgar.xml","form_type":"4"}},{"id":2741746,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-22T17:58:12.000Z","date":"2021-04-20","kind":"grant","acquired":true,"shares":26923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on April 20, 2022. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":67429,"source":{"system":"sec-edgar","filing":"0001192482-21-000351","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248221000351/edgar.xml","form_type":"4"}},{"id":2954832,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2020-12-07T16:13:48.000Z","date":"2020-12-03","kind":"sale","acquired":false,"shares":5400,"price":0.165,"value":891.0,"ownership":{"direct":true},"balance_after":11593,"source":{"system":"sec-edgar","filing":"0000950138-20-000521","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000095013820000521/edgar.xml","form_type":"4"}},{"id":3118149,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-08T17:46:28.000Z","date":"2020-06-06","kind":"exercise","acquired":false,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F3","text":"This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying these restricted stock units vested on June 6, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares underlying these restricted stock units vested on June 6, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-20-035059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120035059/doc4.xml","form_type":"4"}},{"id":3118148,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option Grant (right to buy)","published_at":"2020-06-08T17:46:28.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":16500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject this option will vest in twelve equal monthly installments commencing July 4, 2020, subject to Reporting Person's continuous service through each such date."}],"balance_after":16500,"derivative":{"exercise_price":1.41,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16500},"source":{"system":"sec-edgar","filing":"0001209191-20-035059","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120035059/doc4.xml","form_type":"4"}},{"id":3118147,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T17:46:28.000Z","date":"2020-06-06","kind":"exercise","acquired":true,"shares":7333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":16209,"source":{"system":"sec-edgar","filing":"0001209191-20-035059","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120035059/doc4.xml","form_type":"4"}},{"id":3153976,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-11T17:05:53.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":12405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 7, 2021."}],"balance_after":12405,"derivative":{"exercise_price":8.37,"expiration_date":"2030-05-07","underlying":"Common Stock","underlying_shares":12405},"source":{"system":"sec-edgar","filing":"0001192482-20-000339","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248220000339/edgar.xml","form_type":"4"}},{"id":3153975,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-11T17:05:53.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":8363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 7, 2021. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":40506,"source":{"system":"sec-edgar","filing":"0001192482-20-000339","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248220000339/edgar.xml","form_type":"4"}},{"id":3182433,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2020-04-03T16:40:37.000Z","date":"2020-04-01","kind":"tax_withholding","acquired":false,"shares":986,"price":1.93,"value":1902.98,"ownership":{"direct":true},"balance_after":16993,"source":{"system":"sec-edgar","filing":"0000950138-20-000202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000095013820000202/edgar.xml","form_type":"4"}},{"id":3226491,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T16:27:47.000Z","date":"2020-03-02","kind":"exercise","acquired":false,"shares":8876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8876},"source":{"system":"sec-edgar","filing":"0001209191-20-016088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120016088/doc4.xml","form_type":"4"}},{"id":3226490,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted stock units","published_at":"2020-03-04T16:27:47.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":8876,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The shares underlying these restricted stock units vest immediately."}],"balance_after":8876,"derivative":{"underlying":"Common Stock","underlying_shares":8876},"source":{"system":"sec-edgar","filing":"0001209191-20-016088","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120016088/doc4.xml","form_type":"4"}},{"id":3226489,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T16:27:47.000Z","date":"2020-03-02","kind":"exercise","acquired":true,"shares":8876,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."}],"balance_after":8876,"source":{"system":"sec-edgar","filing":"0001209191-20-016088","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919120016088/doc4.xml","form_type":"4"}},{"id":3347879,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-09T18:29:37.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":9156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the \"Company\") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued service with the Company."}],"balance_after":32143,"source":{"system":"sec-edgar","filing":"0001192482-19-000492","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248219000492/edgar.xml","form_type":"4"}},{"id":3495349,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-06-10T16:50:00.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":7333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made pursuant to the issuer's amended and restated non-employee director compensation policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying these restricted stock units vest on June 6, 2020, subject to the Reporting Person's continuous service with the issuer as of the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares underlying these restricted stock units vest on June 6, 2020, subject to the Reporting Person's continuous service with the issuer as of the vesting date."}],"balance_after":7333,"derivative":{"underlying":"Common Stock","underlying_shares":7333},"source":{"system":"sec-edgar","filing":"0001209191-19-035830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919119035830/doc4.xml","form_type":"4"}},{"id":3496772,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-06-07T16:12:22.000Z","date":"2019-06-07","kind":"purchase","acquired":true,"shares":5400,"price":8.9599,"value":48383.46,"ownership":{"direct":true},"balance_after":17979,"source":{"system":"sec-edgar","filing":"0000950138-19-000343","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000095013819000343/edgar.xml","form_type":"4"}},{"id":3531167,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T16:25:38.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":10888,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 9, 2020."}],"balance_after":10888,"derivative":{"exercise_price":8.8,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":10888},"source":{"system":"sec-edgar","filing":"0001192482-19-000244","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248219000244/edgar.xml","form_type":"4"}},{"id":3531166,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-10T16:25:38.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":7955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 9, 2020. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":22987,"source":{"system":"sec-edgar","filing":"0001192482-19-000244","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248219000244/edgar.xml","form_type":"4"}},{"id":3563791,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2019-04-03T18:16:43.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":57569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal annual installments beginning April 1, 2020."}],"balance_after":57569,"derivative":{"exercise_price":22.26,"exercise_date":"2020-04-01","expiration_date":"2029-04-01","underlying":"Ordinary Shares","underlying_shares":57569},"source":{"system":"sec-edgar","filing":"0000950138-19-000233","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000095013819000233/edgar.xml","form_type":"4"}},{"id":3563790,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & CFO"}}],"security":"Ordinary Shares","published_at":"2019-04-03T18:16:43.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":12579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning April 1, 2020."}],"balance_after":12579,"source":{"system":"sec-edgar","filing":"0000950138-19-000233","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000095013819000233/edgar.xml","form_type":"4"}},{"id":3834866,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Class A Common Stock","published_at":"2018-08-23T20:50:59.000Z","date":"2018-08-21","kind":"sale","acquired":false,"shares":11698,"price":23.65,"value":276657.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.55 to $23.78. The reporting person undertakes to provide Amneal Pharmaceuticals, Inc. (the \"Company\"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":82986,"source":{"system":"sec-edgar","filing":"0000899243-18-023153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318023153/doc4.xml","form_type":"4"}},{"id":3934270,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-05-14T16:48:39.000Z","date":"2018-05-12","kind":"exercise","acquired":false,"shares":8849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 8,849 restricted stock units, vesting on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2017, the reporting person was granted 8,849 restricted stock units, vesting on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8849},"source":{"system":"sec-edgar","filing":"0001192482-18-000203","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248218000203/edgar.xml","form_type":"4"}},{"id":3934269,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-14T16:48:39.000Z","date":"2018-05-12","kind":"exercise","acquired":true,"shares":8849,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15032,"source":{"system":"sec-edgar","filing":"0001192482-18-000203","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248218000203/edgar.xml","form_type":"4"}},{"id":3938383,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-10T19:01:41.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":8965,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This amended Form 4 is being filed to correct a typographical error in the number of stock options acquired on May 4, 2018 as reported on the Form 4 filed on May 8, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":8965,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":8965},"source":{"system":"sec-edgar","filing":"0001192482-18-000199","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248218000199/edgar.xml","form_type":"4/A","original_submission_date":"2018-05-08"}},{"id":3942711,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Restricted Stock Units","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":33311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest in four equal annual installments beginning on May 07, 2019 and have no expiration date."}],"balance_after":33311,"derivative":{"underlying":"Class A Common Stock","underlying_shares":33311},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942710,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-07","kind":"grant","acquired":true,"shares":136240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests in four equal annual installments beginning on May 07, 2019."}],"balance_after":136240,"derivative":{"exercise_price":15.01,"expiration_date":"2028-05-07","underlying":"Class A Common Stock","underlying_shares":136240},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942709,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":52000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":52000,"derivative":{"exercise_price":17.99,"expiration_date":"2023-05-15","underlying":"Class A Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942708,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":55000,"derivative":{"exercise_price":25.24,"expiration_date":"2024-05-14","underlying":"Class A Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942707,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":47500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":47500,"derivative":{"exercise_price":40.7,"expiration_date":"2025-02-26","underlying":"Class A Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942706,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":63095,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":63095,"derivative":{"exercise_price":33.27,"expiration_date":"2026-02-26","underlying":"Class A Common Stock","underlying_shares":63095},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942705,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Option","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":56232,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Received pursuant to the BCA in exchange for an option to purchase an equal number of shares of Impax common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is vested and currently exercisable."}],"balance_after":56232,"derivative":{"exercise_price":9.35,"expiration_date":"2027-03-02","underlying":"Class A Common Stock","underlying_shares":56232},"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942704,"issuer":{"id":820,"kind":"organization","name":"Amneal Pharmaceuticals, Inc.","symbol":"AMRX"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Class A Common Stock","published_at":"2018-05-08T23:22:09.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":94684,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 94,684 shares of Impax Laboratories, Inc. (\"Impax\") common stock pursuant to the Business Combination Agreement, dated as of October 17, 2017, among Impax, Amneal Pharmaceuticals LLC, Atlas Holdings, Inc. and K2 Merger Sub Corporation (as amended, the \"BCA\")."}],"balance_after":94684,"source":{"system":"sec-edgar","filing":"0000899243-18-011942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1723128/000089924318011942/doc4.xml","form_type":"4"}},{"id":3942230,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-08T17:28:21.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":5742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest on May 4, 2019."}],"balance_after":5742,"derivative":{"exercise_price":11.32,"expiration_date":"2028-05-04","underlying":"Common Stock","underlying_shares":5742},"source":{"system":"sec-edgar","filing":"0001192482-18-000185","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248218000185/edgar.xml","form_type":"4"}},{"id":3942229,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-08T17:28:21.000Z","date":"2018-05-04","kind":"grant","acquired":true,"shares":6183,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All shares of common stock are represented by unvested restricted stock units that will vest on May 4, 2019. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":6183,"source":{"system":"sec-edgar","filing":"0001192482-18-000185","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000119248218000185/edgar.xml","form_type":"4"}},{"id":3943054,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":52000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":17.99,"expiration_date":"2023-05-15","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943053,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":55000,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":25.24,"expiration_date":"2024-05-14","underlying":"Common Stock","underlying_shares":55000},"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943052,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":47500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":40.7,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":47500},"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943051,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":63095,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":33.27,"expiration_date":"2026-02-26","underlying":"Common Stock","underlying_shares":63095},"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943050,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":56232,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options disposed of pursuant to the terms of the BCA, according to which each Option held by the reporting person fully vested and was exchanged for an option to acquire a number of shares of Class A Common Stock equal to the number of shares of Common Stock subject to such Option in connection with the closing of the transactions contemplated by the BCA, at a per-share exercise price equal to the per-share exercise price of such Option."}],"balance_after":0,"derivative":{"exercise_price":9.35,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":56232},"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943049,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Common Stock","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":20566,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock.  Amount represents net amount of shares exchanged after required tax withholding with respect to such vesting."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares of restricted common stock disposed of pursuant to the terms of the BCA, according to which each share of restricted stock held by the reporting person fully vested and was exchanged for one share of Class A Common Stock.  Amount represents net amount of shares exchanged after required tax withholding with respect to such vesting."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3943048,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-08T16:08:54.000Z","date":"2018-05-04","kind":"disposition_to_issuer","acquired":false,"shares":53423,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Common Stock disposed of pursuant to the terms of the Business Combination Agreement, dated as of October 17, 2017 (the \"BCA\"), by and among Impax Laboratories, Inc., Atlas Holdings, Inc. (\"Holdco\"), K2 Merger Sub Corporation and Amneal Pharmaceuticals LLC, as amended by Amendment No. 1, dated as of November 21, 2017, and Amendment No. 2, dated as of December 16, 2017, according to which each share of Common Stock held by the reporting person was converted into the right to receive one share of Class A common stock of Holdco (\"Class A Common Stock\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001003642-18-000078","document":"wf-form4_152581008008892.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000078/wf-form4_152581008008892.xml","form_type":"4"}},{"id":3958470,"issuer":{"id":5041,"kind":"organization","name":"Aclaris Therapeutics, Inc."},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-04-23T18:29:41.000Z","date":"2018-04-20","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will vest and become exercisable in 36 equal monthly installments through April 20, 2021, subject to the reporting person's\ncontinuous service as of such vesting dates."}],"balance_after":16000,"derivative":{"exercise_price":17.73,"expiration_date":"2028-04-19","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-18-025908","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000120919118025908/doc4.xml","form_type":"4"}},{"id":4017021,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-03-05T12:46:33.000Z","date":"2018-03-02","kind":"tax_withholding","acquired":false,"shares":3069,"price":19.5,"value":59845.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":94684,"source":{"system":"sec-edgar","filing":"0001003642-18-000046","document":"wf-form4_152027197326277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000046/wf-form4_152027197326277.xml","form_type":"4"}},{"id":4031432,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-02-27T12:19:14.000Z","date":"2018-02-26","kind":"tax_withholding","acquired":false,"shares":6141,"price":20.95,"value":128653.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of two restricted stock awards to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":97753,"source":{"system":"sec-edgar","filing":"0001003642-18-000023","document":"wf-form4_151975193527224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364218000023/wf-form4_151975193527224.xml","form_type":"4"}},{"id":4317766,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-05-16T16:30:40.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":8849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Company's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest on May 12, 2018. Vested shares will be delivered to the reporting person within 30 days following the vesting date."}],"balance_after":8849,"derivative":{"underlying":"Common Stock","underlying_shares":8849},"source":{"system":"sec-edgar","filing":"0001123292-17-000944","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000112329217000944/edgar.xml","form_type":"4"}},{"id":4319107,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T14:54:36.000Z","date":"2017-05-15","kind":"tax_withholding","acquired":false,"shares":454,"price":16.8,"value":7627.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":103894,"source":{"system":"sec-edgar","filing":"0001003642-17-000044","document":"wf-form4_149496086190888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000044/wf-form4_149496086190888.xml","form_type":"4"}},{"id":4319106,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-05-16T14:54:36.000Z","date":"2017-05-14","kind":"tax_withholding","acquired":false,"shares":705,"price":17.65,"value":12443.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":104348,"source":{"system":"sec-edgar","filing":"0001003642-17-000044","document":"wf-form4_149496086190888.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000044/wf-form4_149496086190888.xml","form_type":"4"}},{"id":4399838,"issuer":{"id":92137,"kind":"organization","name":"Societal CDMO, Inc.","symbol":"SCTL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-06T16:59:32.000Z","date":"2017-03-03","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal installments on March 3, 2018, 2019, and 2020."}],"balance_after":20000,"derivative":{"exercise_price":7.63,"expiration_date":"2027-03-03","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001123292-17-000562","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1553489/000112329217000562/edgar.xml","form_type":"4"}},{"id":4401185,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-06T15:08:02.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":56232,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in four equal installments beginning on March 2, 2018, which is the first anniversary of the grant date."}],"balance_after":56232,"derivative":{"exercise_price":9.35,"expiration_date":"2027-03-02","underlying":"Common Stock","underlying_shares":56232},"source":{"system":"sec-edgar","filing":"0001003642-17-000019","document":"wf-form4_148883086849313.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000019/wf-form4_148883086849313.xml","form_type":"4"}},{"id":4401184,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-03-06T15:08:02.000Z","date":"2017-03-02","kind":"grant","acquired":true,"shares":23272,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105053,"source":{"system":"sec-edgar","filing":"0001003642-17-000019","document":"wf-form4_148883086849313.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000019/wf-form4_148883086849313.xml","form_type":"4"}},{"id":4422569,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-27T20:23:21.000Z","date":"2017-02-26","kind":"tax_withholding","acquired":false,"shares":5715,"price":14.05,"value":80295.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of two restricted stock awards to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":81781,"source":{"system":"sec-edgar","filing":"0001003642-17-000012","document":"wf-form4_148824498735141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364217000012/wf-form4_148824498735141.xml","form_type":"4"}},{"id":4573620,"issuer":{"id":14052,"kind":"organization","name":"Impax Laboratories, LLC","symbol":"IPXL"},"owners":[{"id":76959,"kind":"person","name":"Reasons Bryan M.","position":1,"cik":"0001553489","reported_name":"Reasons Bryan M.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2016-10-27T12:05:18.000Z","date":"2016-10-26","kind":"tax_withholding","acquired":false,"shares":1209,"price":21.35,"value":25812.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were withheld by the issuer upon the vesting of a restricted stock award to satisfy Mr. Reasons' payroll tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":87496,"source":{"system":"sec-edgar","filing":"0001003642-16-000038","document":"wf-form4_147758430494937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1003642/000100364216000038/wf-form4_147758430494937.xml","form_type":"4"}}]}